FSMDX
Price
$42.17
Change
-$0.03 (-0.07%)
Updated
Jul 22 closing price
Net Assets
53.23B
VIMSX
Price
$87.91
Change
-$0.02 (-0.02%)
Updated
Jul 22 closing price
Net Assets
223.97B
Interact to see
Advertisement

FSMDX vs VIMSX

FSMDX vs VIMSX Comparison Chart in %
View a ticker or compare two or three
VS
FSMDX vs. VIMSX commentary
Jul 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 224B vs. FSMDX (53.2B). VIMSX pays higher dividends than FSMDX: VIMSX (1.20) vs FSMDX (0.76). FSMDX was incepted earlier than VIMSX: FSMDX (15 years) vs VIMSX (28 years). VIMSX (0.17) is less costly to investors than FSMDX (0.03). VIMSX is a more actively managed with annual turnover of: 16.00 vs. FSMDX (15.00). FSMDX has a lower initial minimum investment than VIMSX: FSMDX (0) vs VIMSX (3000). FSMDX annual gain was more profitable for investors over the last year : 17.33 vs. VIMSX (12.76). FSMDX return over 5 years is better than : 42.95 vs. VIMSX (35.73).
FSMDXVIMSXFSMDX / VIMSX
Total Expense Ratio0.030.1715%
Annual Report Gross Expense Ratio0.030.1715%
Fund Existence15 years28 years-
Gain YTD14.27011.056129%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets53.2B224B24%
Annual Yield % from dividends0.761.2063%
Returns for 1 year17.3312.76136%
Returns for 3 years50.0442.52118%
Returns for 5 years42.9535.73120%
Returns for 10 years162.15154.74105%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCYSX16.310.02
+0.12%
NYLI Candriam Emerging Markets Eq Cl R6
CMNWX90.53N/A
N/A
Principal Capital Appreciation A
GSGCX50.18N/A
N/A
Goldman Sachs Equity Income C
VBINX54.11N/A
N/A
Vanguard Balanced Index Inv
WSMRX30.56-0.21
-0.68%
William Blair Small-Mid Cap Growth R6